Moderate to Severe Genital Psoriasis
1 clinical trials · Condition
◉ Watch Moderate to Severe Genital Psoriasis
| Record | Firm | Date |
|---|---|---|
| A Study to Evaluate the Efficacy and Safety of Subcutaneous Tildrakizumab in Subjects With Moderate to Severe Genital Psoriasis. (NCT06611163) | Sun Pharmaceutical Industries Limited | 2025-03-21 |
Track Moderate to Severe Genital Psoriasis automatically
Every clearance here is in the API, with alerts when new ones post.